Raras
Buscar doenças, sintomas, genes...
Síndrome de perturbação do desenvolvimento intelectual-ataxia-hipotonia-dismorfia facial
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A monocelha é uma única sobrancelha formada quando as duas sobrancelhas se encontram no meio, acima da ponte do nariz. Os pelos acima da ponte do nariz têm a mesma cor e espessura que as sobrancelhas, de modo que convergem para formar uma linha de pelos ininterrupta.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
62
pacientes catalogados
Início
Antenatal
+ infancy, neonatal
🏥
SUS: Cobertura mínimaScore: 35%
Centros em: PA, PR, RS, ES, RJ +5CID-10: Q87.0
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

😀
Face
16 sintomas
🧠
Neurológico
12 sintomas
👁️
Olhos
4 sintomas
👂
Ouvidos
3 sintomas
🫃
Digestivo
2 sintomas
🦴
Ossos e articulações
2 sintomas

+ 28 sintomas em outras categorias

Características mais comuns

100%prev.
Micropênis
Obrigatório (100%)
100%prev.
Marcha de base alargada
Frequência: 3/3
100%prev.
Disfagia
Frequência: 3/3
100%prev.
Hipotonia generalizada
Frequência: 8/8
100%prev.
Fraqueza da musculatura facial
Frequência: 3/3
92%prev.
Atraso global do desenvolvimento
Frequência: 12/13
70sintomas
Muito frequente (10)
Frequente (32)
Ocasional (24)
Sem dados (4)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 70 características clínicas mais associadas, ordenadas por frequência.

MicropênisMicropenis
Obrigatório (100%)100%
Marcha de base alargadaBroad-based gait
Frequência: 3/3100%
DisfagiaDysphagia
Frequência: 3/3100%
Hipotonia generalizadaGeneralized hypotonia
Frequência: 8/8100%
Fraqueza da musculatura facialWeakness of facial musculature
Frequência: 3/3100%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1
Últimos 10 anos200publicações
Pico2026151 papers
Linha do tempo
2025Hoje · 2026
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal dominant.

EBF3Transcription factor COE3Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcriptional activator (PubMed:28017370, PubMed:28017372, PubMed:28017373). Recognizes variations of the palindromic sequence 5'-ATTCCCNNGGGAATT-3' (By similarity)

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Hypotonia, ataxia, and delayed development syndrome

An autosomal dominant neurodevelopmental syndrome characterized by global developmental delay, moderate to severe intellectual disability, cerebellar ataxia, hypotonia, speech delay, variable dysmorphic features, and genitourinary abnormalities including vesicoureteric reflux.

EXPRESSÃO TECIDUAL(Ubíquo)
Tecido adiposo
37.0 TPM
Nervo tibial
25.6 TPM
Adipose Visceral Omentum
21.2 TPM
Mama
18.9 TPM
Tireoide
13.9 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
hypotonia, ataxia, and delayed development syndromedistal 10q deletion syndrome
HGNC:19087UniProt:Q9H4W6

Variantes genéticas (ClinVar)

272 variantes patogênicas registradas no ClinVar.

🧬 EBF3: NM_001375380.1(EBF3):c.541G>A (p.Val181Ile) ()
🧬 EBF3: NM_001375380.1(EBF3):c.935G>A (p.Arg312Gln) ()
🧬 EBF3: NM_001375380.1(EBF3):c.1372+1G>A ()
🧬 EBF3: GRCh37/hg19 10q26.13-26.3(chr10:126513306-135427143)x1 ()
🧬 EBF3: GRCh37/hg19 10q26.3(chr10:131515269-135427143)x1 ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de perturbação do desenvolvimento intelectual-ataxia-hipotonia-dismorfia facial

Centros de Referência SUS

13 centros habilitados pelo SUS para Síndrome de perturbação do desenvolvimento intelectual-ataxia-hipotonia-dismorfia facial

Centros para Síndrome de perturbação do desenvolvimento intelectual-ataxia-hipotonia-dismorfia facial

Detalhes dos centros

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Novel Variants in PTPN11, NF1, RASA2, and MAP2K1: Expanding the Molecular Spectrum of RASopathies in a Turkish Cohort.

Clinical genetics2026 Mar 19

RASopathies are a group of genetically heterogeneous developmental disorders caused by germline variants affecting the RAS/MAPK signaling pathway. These disorders display overlapping clinical features and diverse molecular mechanisms. This study aimed to evaluate the clinical and molecular spectrum of patients diagnosed with RASopathies, with a particular focus on novel and rare variants. A retrospective, multicenter study was conducted on patients with clinically suspected RASopathy and diagnosed by targeted Next Generation Sequencing analysis between 2021 and 2024. Variants were classified according to ACMG criteria, and clinical data were reviewed for genotype-phenotype correlations. Among 23 patients (14 males, 9 females), 15 (65.2%) had Noonan syndrome, five (21.7%) Neurofibromatosis Type 1, two (8.7%) Cardio-facio-cutaneous syndrome, and one (4.3%) Neurofibromatosis-Noonan syndrome. The most frequent clinical findings were craniofacial dysmorphism (91.3%), musculoskeletal anomalies (82.6%), and cutaneous features (78.3%). A total of 24 heterozygous variants were identified in seven genes: PTPN11 (45.8%), NF1 (25%), LZTR1 (12.5%), and RASA2, SOS1, MAP2K1, and BRAF (each 4.2%). Four novel variants were detected (PTPN11 c.853 + 4A>G, RASA2 p.E71D, NF1 p.W784Mfs*10, MAP2K1 p.A106T). This study highlights the clinical and molecular heterogeneity of RASopathies and expands the variant spectrum with novel and rare pathogenic alterations. The identification of new variants, particularly in rarely implicated genes such as RASA2, underlines the diagnostic value of comprehensive NGS-based testing and the need for individualized, multidisciplinary clinical management.

#2

Biallelic SUPT4H1 Variants Cause a Multisystem Neurodevelopmental Disorder Associated with Disrupted Transcription.

Genetics in medicine : official journal of the American College of Medical Genetics2026 Mar 14

We aimed to define the clinical and genetic basis of an autosomal recessive neurodevelopmental disorder identified in three unrelated families with an overlapping multisystem phenotype. Exome or genome sequencing was performed in six affected individuals from three families, revealing biallelic variants in SUPT4H1. Functional effects were evaluated using CRISPR and RNAi knockdown in C. elegans. Transcriptomic and proteomic profiling were conducted on patient-derived fibroblasts. Phylogenetic profiling assessed evolutionary conservation and co-evolution. Dopamine response was evaluated in two affected siblings. All individuals carried biallelic SUPT4H1 variants-one frameshift and two missense variants. Shared features included intellectual disability, dystonia, speech impairment, craniofacial dysmorphism, skeletal anomalies, and enamel hypoplasia. Functional modeling in C. elegans confirmed pathogenicity through neuromotor deficits. Multi-omics analyses revealed dysregulation of developmental gene networks and the transcriptional machinery with disrupted RNA polymerase complexes and cell cycle regulators. Dopamine treatment improved motor symptoms and normalized cerebrospinal neurotransmitter levels in two siblings. Biallelic variants in SUPT4H1 cause a previously unrecognized multisystem neurodevelopmental disorder. These findings underscore the importance of disrupted transcription in human disease and demonstrate how integrated multi-omics and cross-species modeling can reveal underlying mechanisms and provide a foundation for future studies of transcriptional regulation.

#3

Protocol for an open-label, randomised, controlled trial to evaluate the efficacy and safety of sotatercept add-on therapy compared with pulmonary vasodilator-based standard of care for pulmonary vasodilator-resistant pulmonary arterial hypertension associated with unrepaired congenital shunts (atrial septal defect, ventricular septal defect or patent ductus arteriosus), including Eisenmenger syndrome: the SuMILE trial.

BMJ open2026 Mar 12

Eisenmenger syndrome and pulmonary arterial hypertension (PAH) due to unrepaired congenital shunts, including atrial septal defect (ASD), ventricular septal defect (VSD) and patent ductus arteriosus (PDA), remain life-threatening conditions despite advances in congenital heart disease (CHD) care. In this population, vasodilator-based therapies effective in other forms of PAH have shown limited benefit, and no disease-modifying treatment has been established. Sotatercept, an activin-signalling inhibitor, improved exercise capacity and haemodynamics in phase 2/3 PAH trials; however, patients with unrepaired CHD, including Eisenmenger syndrome, were excluded. The efficacy and safety of sotatercept in this population remain unknown. The SuMILE trial is a prospective, exploratory, multicentre, open-label, randomised, controlled trial conducted at 11 Japanese tertiary centres. 36 adults with vasodilator-resistant PAH due to unrepaired ASD, VSD or PDA, including Eisenmenger syndrome, will be randomised 2:1 to sotatercept add-on therapy plus vasodilator-based PAH therapy versus vasodilator-based PAH therapy alone. Sotatercept will be administered subcutaneously every 3 weeks in accordance with label-approved dose-modification rules for haemoglobin and platelet changes. The primary endpoint is the change in 6-min walk distance from baseline to week 24. Key clinical events will be independently adjudicated. Secondary endpoints include all-cause mortality or lung transplantation; pulmonary hypertension-related hospitalisation or initiation of parenteral prostacyclin and changes in WHO functional class, N-terminal pro-brain natriuretic peptide and emPHasis-10. Exploratory endpoints include genotype, right heart catheterisation and cardiac MRI parameters. The primary analysis will use ANCOVA, adjusting for baseline 6-min walk distance and randomisation stratum in the intention-to-treat population. The protocol has been reviewed and approved by the certified central review board (Kyushu University Hospital Clinical Ethics Review Board) and participating institutions. Written informed consent will be obtained from all participants. Findings will be disseminated through peer-reviewed journals, scientific conferences and trial registries. Japan Registry of Clinical Trials no. 1071250069; ClinicalTrials.gov NCT07356778. Protocol version and date: V.1.3; 23 October 2025.

#4

Expanding the Coffin-Siris syndrome spectrum: genetic, dysmorphic, and endocrine findings in eight cases.

European journal of pediatrics2026 Mar 08

This study aims to expand the spectrum of Coffin-Siris syndrome (CSS), a rare and heterogeneous disorder, by thoroughly discussing its genetic, dysmorphic, and endocrine features through new cases and contributing to the literature. Eight patients who were referred to the genetics clinic with various complaints and subsequently diagnosed with CSS through microarray or clinical exome sequencing analyses were included in the study. The dysmorphic, genetic, and endocrine characteristics of eight genetically confirmed patients were evaluated. The patients, aged between 5 months and 6 years at the time of referral, comprised four females and four males. The most common reasons for referral were developmental delay and dysmorphic features. All patients exhibited varying degrees of dysmorphic facial features. Hypertrichosis, a typical feature of the syndrome, was present in five patients. Another characteristic finding was mild hypoplasia of the terminal fifth phalanges, observed in patients 1, 2, and 6. Consistent with this, mild/subtle hypoplasia and/or slight positional changes of the fifth fingernails were noted in these patients, rather than overt nail anomalies. In our study, eight variants were identified, two of which were novel. In our cohort, pathological short stature was observed in three patients, while hypothyroidism, transient hypercalcemia, cryptorchidism, and recurrent fractures were each identified in one patient. All three patients with short stature had delayed bone age with head circumference and BMI <  - 2 SDS. Seven patients were diagnosed with ARID1B-related CSS type 1, while one patient was diagnosed with SMARCA4-related CSS type 4. Among the eight findings across patients, two were deletion-type copy-number variations (CNVs) identified by microarray analysis, and six were sequence variants: two frameshift, two splice-site, one nonsense, and one synonymous. Seven variants were classified as pathogenic and one as likely pathogenic. Family studies confirmed that the variants were de novo and validated their clinical relevance.  CSS is a clinically and genetically heterogeneous syndrome. Patients may present with highly variable features, and typical signs of the syndrome may not be observed in all cases. This study expands the clinical spectrum of this rare syndrome and contributes to its genetic spectrum with the identification of new variants. • Coffin-Siris syndrome (CSS) is a clinically and genetically heterogeneous neurodevelopmental disorder most commonly caused by variants in SWI/SNF (BAF) complex genes (e.g., ARID1B, SMARCA4) and characterized by dysmorphic features, developmental delay, hypertrichosis, and fifth-digit/nail anomalies. • Endocrine and growth-related manifestations can occur in CSS, but their frequency and phenotypic range vary across cohorts and require individualized clinical follow-up. • This case series of eight genetically confirmed CSS patients (7 ARID1B, 1 SMARCA4) expands the phenotypic spectrum by detailing dysmorphic findings together with endocrine features including pathological short stature with delayed bone age, hypothyroidism, transient hypercalcemia, cryptorchidism, and recurrent fractures. • We identified eight pathogenic/likely pathogenic variants, including two novel variants, and highlight that fifth digit/nail involvement may be subtle (mild terminal fifth phalanx hypoplasia and minor fifth nail changes) rather than overt.

#5

Child Neurology: Multiple Genetic Etiologies Causing Dandy-Walker Variant With Microcephaly, Epilepsy, and Global Developmental Delay.

Neurology2026 Apr 14

Dandy-Walker syndrome is typically characterized by near-complete cerebellar vermis agenesis, enlarged posterior fossa, and dilated fourth ventricle. By contrast, Dandy-Walker variant (DWv) shows milder features, typically characterized by partial agenesis of the cerebellar vermis, mild enlargement of the posterior fossa, and variable dilation of the fourth ventricle. Both conditions are usually associated with normal or enlarged head circumference. We report a 16-month-old girl presenting with congenital microcephaly, frequent seizures, and severe global developmental delay. Brain MRI revealed findings consistent with DWv, which did not explain the severity of her clinical symptoms or her microcephaly. Chromosomal microarray analysis revealed multiple regions of homozygosity on chromosome 11, indicating potential recessive inheritance; karyotype analysis and mitochondrial testing showed no clear etiology. Trio-based whole-exome sequencing identified a heterozygous variant (NM_021096.4:c.4891T>A/p.Phe1631Ile) in CACNA1I and a homozygous variant (NM_002335.4:c.1310C>T/p.Thr437Met) in LRP5. Variants in CACNA1I are associated with neurodevelopmental disorders, including epilepsy and developmental delay, while variants in LRP5 are linked to osteoporosis and microcephaly. Based on the clinical presentation and molecular findings, we hypothesize that both variants contributed to the patient's complex phenotype. This case highlights that in patients with unusually severe or atypical manifestations, the possibility of multiple genetic pathogenic contributions should be considered, and comprehensive genomic evaluation is essential for accurate diagnosis and management.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 200

2026

Clinical and genetic basis of congenital gonadotropin deficiency.

Human reproduction open
2026

Update on Congenital Cranial Dysinnervation Disorders (CCDDs).

International ophthalmology clinics
2026

Etiological Diagnosis and Disease Course of Birk-Barel Syndrome in an Adult Woman with a KCNK9 Variant.

International medical case reports journal
2026

A New Patient With SPOUT1-Related Neurodevelopmental Disorder Identified by Genomic Data Re-Analysis: Novel Phenotypic Features and Literature Review.

American journal of medical genetics. Part A
2026

Complex Genetic Architecture in RASopathies: Constitutional PTPN11 and Mosaic RIT1 Pathogenic Variants Underlying Severe Noonan Syndrome With Adult-Onset Acute Myeloid Leukemia.

American journal of medical genetics. Part A
2026

Novel Variants in PTPN11, NF1, RASA2, and MAP2K1: Expanding the Molecular Spectrum of RASopathies in a Turkish Cohort.

Clinical genetics
2025

Clinical and molecular findings in Cornelia de Lange syndrome. Case series.

Andes pediatrica : revista Chilena de pediatria
2026

Biallelic SUPT4H1 Variants Cause a Multisystem Neurodevelopmental Disorder Associated with Disrupted Transcription.

Genetics in medicine : official journal of the American College of Medical Genetics
2026

Identification of a novel NSD1 pathogenic variant in a Senegalese child with Sotos syndrome.

Journal, genetic engineering &amp; biotechnology
2026

Strengthening Undergraduate Medical Education for Inclusive Health Care for People With Down Syndrome and Intellectual and Developmental Disabilities in Medical Schools: Protocol for a Scoping Review.

JMIR research protocols
2026

OTUD5-related rare X-linked multiple congenital anomalies and neurodevelopmental syndrome: clinical findings and review of the literature.

Neurogenetics
2026

First reported case of developmental dysplasia of the hips in a child with 3M syndrome: a case report.

Journal of surgical case reports
2026

The 9th International RASopathies Symposium.

American journal of medical genetics. Part A
2026

A novel KDM6A c.2429dup mutation causing kabuki syndrome type 2 identified in a fetus with increased nuchal translucency.

The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
2026

The Management of Evolving Neuropsychiatric Symptoms in a Female with Fragile X Syndrome: A Case Report.

Psychopharmacology bulletin
2026

Protocol for an open-label, randomised, controlled trial to evaluate the efficacy and safety of sotatercept add-on therapy compared with pulmonary vasodilator-based standard of care for pulmonary vasodilator-resistant pulmonary arterial hypertension associated with unrepaired congenital shunts (atrial septal defect, ventricular septal defect or patent ductus arteriosus), including Eisenmenger syndrome: the SuMILE trial.

BMJ open
2026

Oculoskeletodental syndrome: expansion and review of the clinical and molecular phenotype.

Clinical dysmorphology
2026

Optimizing Diagnostic Accuracy of Clinical Red Flags in RASopathies.

American journal of medical genetics. Part A
2025

[Analysis of clinical features and genetic variants in a Chinese pedigree affected with Spondyloepiphyseal dysplasia type Ehlers-Danlos syndrome due to variants of B3GALT6 gene].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2026

Novel ANKRD11 Mutation in KBG Syndrome: A diagnostic triad of hearing loss, radiological macrodontia and artificial intelligence-assisted facial phenotyping.

Sultan Qaboos University medical journal
2026

De Novo 3q27.1 Microdeletion Refines the Critical Region and Implicates PSMD2 Haploinsufficiency in Growth and Neurodevelopmental Abnormalities.

American journal of medical genetics. Part A
2026

Expanding the Coffin-Siris syndrome spectrum: genetic, dysmorphic, and endocrine findings in eight cases.

European journal of pediatrics
2026

Organ-Specific Histopathological Effects of Prenatal Alcohol Exposure: A Narrative Review.

Congenital anomalies
2026

Child Neurology: Multiple Genetic Etiologies Causing Dandy-Walker Variant With Microcephaly, Epilepsy, and Global Developmental Delay.

Neurology
2026

Case Report: Identification of a de novo missense variant in the N-terminal zinc-finger domain of ZEB2 in a patient presenting with neurodevelopmental delay and recurrent pulmonary infections.

Frontiers in genetics
2026

Navigating challenges: a child with Apert syndrome and global developmental delay from a low-income family.

BMJ case reports
2026

Context-dependent effects of adaptive immunity on IFN-α-mediated neurotoxicity in Aicardi-Goutières syndrome.

Neurobiology of disease
2026

Updating guidelines for the diagnosis of fetal alcohol spectrum disorders (FASD) in Poland.

Advances in clinical and experimental medicine : official organ Wroclaw Medical University
2026

Etiological Analysis and Classification of 108 Patients with Infantile Epileptic Spasms Syndrome Based on the 2017 International League Against Epilepsy Classification.

Noro psikiyatri arsivi
2026

Animal models of hypoplastic left heart syndrome: genetic and anatomical approaches.

Pediatric research
2026

Comparative Evaluation of Sella Turcica Morphology and Dimensions in Skeletal Class III Malocclusion and Cleft Lip and Palate Patients Versus Class I Individuals.

Clinical and experimental dental research
2026

Elevated gamma spectral event peak power during auditory chirp is associated with neuropsychiatric features in Fragile X syndrome.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
2026

A Novel ATXN7L3 De Novo Variant Underlies Harel-Tora Neurodevelopmental Syndrome (HATONS) With Pre-Axial Polydactyly.

Clinical genetics
2026

Cell-type-specific alternative splicing in the brain and kidney of a Setbp1S858R Schinzel-Giedion syndrome mouse.

Disease models &amp; mechanisms
2026

Congenital Temporomandibular Joint Ankylosis: Investigating Potential Genetic Etiologies with Whole Exome Sequencing.

Journal of clinical medicine
2026

Sleep-Disordered Breathing in Chung-Jansen Syndrome.

International journal of molecular sciences
2026

Xp22.33 Duplication Encompassing PAR1 in a Male with Syndromic Neurodevelopmental Disorder and Tall Stature.

Genes
2026

Foundations of an Ovine Model of Fragile X Syndrome.

Genes
2026

A Splice Acceptor Variant in DLL3 Is Associated with Spondylocostal Dysostosis in a Litter of Mixed-Breed Dogs.

Genes
2026

A Clinical Practice Example of Smith-Magenis Syndrome in the Neuropediatric Clinic: Etiology, Clinical Presentation, Diagnostics and Therapeutic Approaches-A Case Report.

Children (Basel, Switzerland)
2026

Orofacial clefting in PHF6-related Börjeson-Forssman-Lehmann syndrome.

BMJ case reports
2026

A Novel Association Between Mandibulofacial Dysostosis with Microcephaly and Congenital Diaphragmatic Hernia.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
2026

Congenital core myopathy linked to SOX5: Expanding the phenotypical spectrum of Lamb-Shaffer syndrome.

Journal of neuromuscular diseases
2026

Comprehensive Clinical, Diagnostic, and In Silico Assessment of a Novel 1p36.33p36.32 Copy Number Variant.

Journal of cellular and molecular medicine
2026

Double Mosaicism in Xia-Gibbs Syndrome.

American journal of medical genetics. Part A
2026

Cardiac conduction system malformations in heterotaxy result from dysregulated Pitx2 expression.

JCI insight
2026

Exploring the Impact of RNU4-2 Defects on Neurodevelopmental Disorders in a Korean Population.

Clinical genetics
2026

Case Report: A female case of X-linked intellectual disability syndrome type 34 caused by a NONO frameshift variant and literature review.

Frontiers in pediatrics
2026

Multi-omics investigation of thyroid development and dysfunction in down syndrome.

Human molecular genetics
2026

Bi-allelic variants in FSD1L cause a neurodevelopmental disorder overlapping with L1 syndrome.

American journal of human genetics
2026

Macrocephaly and Characteristic MRI Findings as Early Clues to a Hereditary Overgrowth Syndrome.

Cureus
2026

WDR59 Is Mutated in Individuals With Autosomal Recessive Syndromic Dilated Cardiomyopathy.

Clinical genetics
2026

Communicative Development Inventories (CDIs) in etiologically diverse developmental conditions: A systematic review.

Research in developmental disabilities
2026

Fetal Rapid Eye Movement Sleep Dysfunction as a Potential Early Indicator for NALCN-Related CLIFAHDD Syndrome: A Case Report.

Prenatal diagnosis
2026

First Report of a Child With a DeSanto-Shinawi Syndrome and a Polymorphous Low-Grade Neuroepithelial Tumor of the Young.

American journal of medical genetics. Part A
2026

Börjeson-Forssman-Lehmann Syndrome in a Pediatric Patient: A Four-Year Longitudinal Case Report Focused on Functional Evolution and Rehabilitation.

Cureus
2026

A novel NMD-escaping STAG2 variant associated with syndromic neurodevelopmental delay, growth failure, and distinctive dysmorphism: expanding the phenotype in male patients and literature review.

Gene
2026

Comprehensive analysis of copy number variations in congenital heart defects Tunisian patients: chromosomal microarray analysis insights.

Molecular cytogenetics
2026

Clinical Presentation, Genetics, and Laboratory Testing with Integrated Genetic Analysis of Molecular Mechanisms in Prader-Willi and Angelman Syndromes: A Review.

International journal of molecular sciences
2026

Longitudinal Behavior Phenotype Hallmarks in RNU4-2 Syndrome: Implications for Clinical Management.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
2026

CTBP1 In Brain Development: A Novel Variant c.107G>C,p.(R36P) Leads to a Distinct Neurodevelopmental Disorder.

Journal of neurochemistry
2026

Protective role of early Tnfsf15 upregulation in limiting glomerular injury and proteinuria in experimental Alport Syndrome.

Journal of pharmacological sciences
2026

Four women whose pioneering contributions to science have been largely overlooked.

eLife
2025

Expanding the Clinical Spectrum of RERE-Related Disorders: A Case Report of Neurodevelopmental Disorder with Brain Malformations Including Chiari Type I.

Molecular syndromology
2026

Nager Syndrome Revisited: Integrating In Vivo and In Vitro Models to Decipher SF3B4-Dependent Tissue Coordination.

WIREs mechanisms of disease
2026

A human electrophysiological signature of Fragile X pathophysiology is shared in V1 of Fmr1-/y mice.

Nature communications
2025

ASXL3 gene variants causing Bainbridge-Ropers syndrome: clinical and genetic analysis of four Chinese patients.

Frontiers in neuroscience
2026

Rapid Eye Movement (REM) Sleep Behaviour Disorder in Moebius Syndrome: A Rare Pediatric Case.

Cureus
2026

MSTO1-related mitochondrial myopathy and ataxia syndrome: Case series and literature review.

Neuromuscular disorders : NMD
2026

Analysis of Eya1 and Tbx1 mutants highlights interactions between the muscle and developing cartilage during external ear formation.

Development (Cambridge, England)
2026

A case with a de novo chromosome 8.9 Mb 11pter duplication and 6.4 Mb 11qter deletion derived from a father with a normal karyotype.

Clinical dysmorphology
2026

Computed Tomography Analysis of Craniofacial Features in Japanese Patients With Cleidocranial Dysplasia.

Congenital anomalies
2025

[Analysis of variants of VPS13B gene in a child with Cohen syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2025

[Analysis of a child with You-Hoover-Fong syndrome due to compound heterozygous variants of the TELO2 gene and a literature review].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2025

[Clinical and genetic analysis of two children with Knobloch syndrome due to variants of COL18A1 gene].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2026

Bi-allelic loss-of-function variants in JKAMP cause a neurodevelopmental syndrome associated with dysregulation of GPR37 trafficking.

American journal of human genetics
2026

Life expectancy of people with intellectual disability: a retrospective cohort study from New South Wales, Australia.

BMJ open
2026

Caregiver-reported social impacts in down syndrome regression disorder.

PloS one
2026

The Ketogenic Diet in the Neonatal Intensive Care Setting: The Case of a Preterm Newborn With Mitochondrial DNA Depletion Syndrome Type 13 (MTDPS13).

Case reports in genetics
2026

A dual-reporter mouse for therapeutic discovery in Angelman syndrome.

JCI insight
2026

Type 2 Diabetes in a Portuguese Adolescent With Hijazi-Reis Syndrome.

Cureus
2026

Muscle Thickness in Lower Extremity and Locomotor Functions in Children With Down Syndrome and Typical Developing Peers.

Journal of intellectual disability research : JIDR
2026

A Patient With Intellectual Disability, Agenesis of Corpus Callosum, and Congenital Heart Disease Associated With Chromosome 10p11.2 Microdeletion.

American journal of medical genetics. Part A
2026

The Role of Pyridoxine Treatment for Seizures in Patients with PGAP3-Congenital Disorders of Glycosylation.

Annals of Indian Academy of Neurology
2026

[Research advance on the clinical phenotypes and molecular genetic mechanisms of Microcephalic primordial dwarfism].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2026

[Prenatal ultrasound manifestations and postnatal follow-up of fetuses with 22q11.2 microdeletion syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2026

The impact of maternal flavivirus infections on fetal neurological outcomes: a scoping review.

Virology journal
2026

Progressive neuroinflammation and deficits in motor function in a mouse model with an Epg5 pathogenic variant of Vici syndrome.

Experimental &amp; molecular medicine
2026

The genetic background of Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome: A systematic review.

Best practice &amp; research. Clinical obstetrics &amp; gynaecology
2026

The 129S1/SvImJ Mouse Strain Is Resistant to the Effects of Early Embryonic Alcohol and Other Sonic Hedgehog Inhibitors.

Birth defects research
2026

Sagittal Craniosynostosis Associated With Chromosome 16p13.3 Duplication.

The Journal of craniofacial surgery
2025

Population developmental hazard of over-the-counter NSAIDs.

Folia medica Cracoviensia
2026

Cognitive and neuropsychomotor development in craniosynostosis: an evaluation of the most affected functions.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2026

Neurodevelopmental outcomes in children with craniosynostosis: a retrospective cross-sectional analysis.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2026

Identification of a Novel TBCK Variation in an Azari Consanguineous Family With Psychomotor Developmental Disorder.

American journal of medical genetics. Part A
2026

Expanding the Phenotype of STAMBP-Related Microcephaly-Capillary Malformation Syndrome.

American journal of medical genetics. Part A
2025

Digital Technologies in Diagnosing Solitary Median Maxillary Central Incisor Syndrome.

Children (Basel, Switzerland)
2026

Interstitial 12p Deletion Syndrome: Revised Minimal Critical Region and Review of the Literature.

Genes
2026

Beyond Neurodevelopmental Delay: BICRA-Related Coffin-Siris Syndrome 12 with Severe Intestinal Dysmotility and Recurrent Pneumothorax.

Genes
2025

Genetic, Epigenetic, and Non-Genetic Factors in Testicular Dysgenesis Syndrome: A Narrative Review.

Genes
2025

A Systematic Review Illustrates the Expanding Clinical and Molecular Landscape of Helsmoortel-Van der Aa Syndrome.

Brain sciences
2026

A novel NSD2 pathogenic variant in a Chinese patient with Rauch-Steindl syndrome: a case report.

BMC neurology
2026

Cohen syndrome with novel VPS13B variants presenting as early-onset diabetes: a case report.

Acta diabetologica
2025

Unveiling Mucopolysaccharidosis IIIC in Brazil: Diagnostic Journey and Clinical Features of Brazilian Patients Identified Through the MPS Brazil Network.

Diseases (Basel, Switzerland)
2025

New Insights into the Relation between Cognition, Behavior, and the CHD5 Gene: A Case-Report of an Adult Male with Parenti-Mignot Neurodevelopmental Syndrome.

Molecular syndromology
2026

Clinical, Psychosocial, and Care Coordination Concerns in Macrocephaly Capillary Malformation Syndrome: Insights From a Large International Survey.

Pediatric blood &amp; cancer
2026

'Pseudo-ataxic' negative myoclonic status in developmental and epileptic encephalopathy with spike-wave activation in sleep: Utility of ACTH therapy beyond west syndrome.

Epileptic disorders : international epilepsy journal with videotape
2026

De novo variants in the splicing factor gene SF3B1 are associated with neurodevelopmental disorders.

Nature communications
2026

A systematic review and meta-analysis of morphosyntactic skills in Williams syndrome.

Acta psychologica
2026

Transcription factor ZEB2 is essential for ureteral smooth muscle cell differentiation.

PLoS genetics
2026

Prenatal Diagnosis of Radio-Tartaglia Syndrome Caused by a Loss-of-Function Variant in SPEN in a Chinese Family.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience
2025

A novel variant in SIAH1 associated with autosomal dominant Buratti-Harel syndrome.

Frontiers in neuroscience
2025

Malformation Pattern and Molecular Findings in the FGFR1-Related Hartsfield Syndrome Phenotype.

Medical sciences (Basel, Switzerland)
2025

Intellectual Developmental Disorder of Autosomal Dominant 61 Caused by a MED13 Variant Presenting With Congenital Unilateral Sensorineural Hearing Loss: A Case Report.

Cureus
2026

Novel variants in STAG2 and PKD1 associate with multiple congenital malformations and autosomal dominant polycystic kidney disease in a Chinese family: A case report and literature review.

Experimental and therapeutic medicine
2026

Long-term benefit of GPi-DBS in YY1-related dystonia: a case report.

Acta neurologica Belgica
2026

Brain volume trajectories in Down syndrome and autosomal dominant Alzheimer's disease.

Alzheimer's &amp; dementia : the journal of the Alzheimer's Association
2026

Identification of novel variants in the ARID1B gene causing Coffin-Siris syndrome.

European journal of pediatrics
2026

Single-cell atlas of the developing Down syndrome brain cortex.

Nature medicine
2026

Loss of Drosophila UBE3A phenocopies Piezo dysfunction and drives hyperphagic feeding in Drosophila.

Fly
2026

AI-Based CT Image Recognition With Med-Gemini-3D in the Diagnosis of a Rare Craniofacial Condition: A Catlin Mark Skull.

The Journal of craniofacial surgery
2026

Caregiver-Reported Attainment of Developmental Skills in Down Syndrome.

Pediatrics
2026

Biallelic Rare COL18A1 Variants in Patients With Neurological Phenotypes Without Severe Ophthalmologic Abnormalities.

Pediatric neurology
2026

Altered hepatic metabolism in Down syndrome.

Cell reports
2026

Fertility preservation and counselling in prepubertal and pubertal girls with Turner syndrome.

Human reproduction (Oxford, England)
2026

Development of a patient-centered conceptual disease model in Ring 14 syndrome: a patient-centered model of lived experience.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
2026

Clinical and Genetic Analysis of SMARCC2-Related Diseases in Three Chinese Patients.

Molecular genetics &amp; genomic medicine
2026

Familial Presentation of a Rare NCKAP1 Splice-Site Variant Associated With a Neurodevelopmental Disorder and Cutaneous Manifestations.

American journal of medical genetics. Part A
2026

Etiology of Infantile Epileptic Spasms Syndrome and Clinical Response With Vigabatrin as the First Treatment.

Pediatric neurology
2026

Gallbladder Agenesis in a Patient With Klinefelter Syndrome Presenting With Hematemesis and Right Upper-Quadrant Pain.

The American journal of case reports
2026

Chromosome engineering to correct a complex rearrangement on Chromosome 8 reveals the effects of 8p syndrome on gene expression and neural differentiation.

Genome research
2026

The Italian Angelman Syndrome Registry (IReAS): a tool for standardized data collection and genotype-phenotype analysis.

European journal of medical genetics
2026

What Motivates Parents of Young Children With Down Syndrome to Participate in Research: A Focus Group Analysis.

Journal of applied research in intellectual disabilities : JARID
2026

Occipital Extracranial Dermoid Cyst in a Neonate With Cardiofaciocutaneous Syndrome Type 4 (CFC4): A Case Report.

Clinical case reports
2026

Proceedings of the 12th International Meeting on Neuroacanthocytosis, Cohen Syndrome, and Other VPS13-Related Disorders.

Tremor and other hyperkinetic movements (New York, N.Y.)
2026

The Sh3Pxd2bnee-/- mouse reveals developmental features of Frank-ter Haar syndrome.

Development (Cambridge, England)
2026

MicroRNAs in fetal alcohol spectrum disorders: A systematic review of prenatal exposure and molecular targets.

Reproductive toxicology (Elmsford, N.Y.)
2025

Whole Exome Sequencing Uncovers Genetic Syndromes Associated with Orofacial Clefts presenting with Limb abnormalities in a Sub-Saharan African cohort.

Research square
2026

The missense mutation Y65C in PQBP1 causes microcephaly and cognitive deficits through a combination of partial loss-of-function and gain-of-function effects.

Nature communications
2026

Temporal transcriptomic changes during neurodevelopment in a mouse model of Smith-Lemli-Opitz syndrome.

The Journal of steroid biochemistry and molecular biology
2026

Explaining the Comprehension-Production Vocabulary Gap Through Neural Networks and Cross-Syndrome Evidence: Insights From Williams Syndrome.

Developmental science
2026

Elevated serotonin receptor 2A signaling restores learning and memory in a Fragile X syndrome model.

Scientific reports
2026

Alterations in electroencephalography signals in female fragile X syndrome mouse model on a C57BL/6J background.

Physiology &amp; behavior
2026

White-Sutton Syndrome: Insight of an Italian Cohort of 19 Subjects.

Clinical genetics
2026

Delayed diagnosis of Townes-Brocks syndrome accompanied with kidney failure.

CEN case reports
2026

Cornelia de Lange syndrome: What should a dermatologist know?

Advances in clinical and experimental medicine : official organ Wroclaw Medical University
2026

Review of early development in children with Down syndrome: family and clinician partnership.

BMJ paediatrics open
2025

Case Report: An exploration of the neurodevelopmental phenotype of five patients with 48,XXYY during early childhood years.

Frontiers in endocrinology
2025

Expanding the Phenotypic Spectrum of FOXC1-Related Axenfeld-Rieger Syndrome Type 3: A Case Report.

Cureus
2026

Novel variant in FGFR2 in a family with anterior segment anomalies.

Ophthalmic genetics
2026

Impact of consanguineous marriage on developmental dental anomalies: a cross-sectional study.

BMC oral health
2026

Clinical and Genetic Significance of Chromosomal Microarray Screening of Asymptomatic Newborns.

Journal of clinical laboratory analysis
2026

Therapeutic GSK-3β targeting stabilizes multifunctional β-catenin to rescue neuronal and behavioral deficits in fragile X messenger ribonucleoprotein 1 knockout mice.

Brain research bulletin
2026

Cerebral Cavernous Malformations Presenting With Epileptic Spasms in Children.

Pediatric neurology
2025

Joint hypermobility as a manifestation of neonatal Sotos syndrome.

BMJ case reports
2026

Case report and literature review of neurodevelopmental syndrome linked to DOT1L variants.

Gene
2026

Results of dedicated venous nitinol stents in treating chronic inferior vena cava occlusions.

Journal of vascular surgery. Venous and lymphatic disorders
2026

Neuropsychiatric signatures across the Alzheimer's disease continuum in Down syndrome and sporadic forms: A biomarker-driven comparison.

Journal of Alzheimer's disease : JAD
2026

NF1-Specific Growth Charts for Head Circumference Over the First 3 Years of Life.

Neurology
2026

Clinical Insights Into a Rare SETD2 Disorder: Report of a Novel Variant.

Developmental neurobiology
2025

Expanding the Genetic Spectrum of Non-Syndromic Cleft Lip and Palate Through Whole-Exome Sequencing.

International journal of molecular sciences
2025

Clinical and Molecular Spectrum of PPP2R1A-Related Neurodevelopmental Disorders: A Systematic Review.

Genes
2025

17q12 Recurrent Deletion Syndrome in Childhood.

Genes
2026

Delayed Dental Development in Children With Non-Syndromic Hypodontia: A Cross-Sectional Study Using a Machine Learning Approach to Dental Age Estimation.

Orthodontics &amp; craniofacial research
2025

Improving variant interpretation and diagnosis in Koolen-de Vries syndrome through a curated genotype-phenotype repository.

Molecular genetics and genomics : MGG
2026

Genotype-Phenotype Correlations in Klinefelter and Turner Syndrome: A Decade of Sex Chromosome Aneuploidy Data From a Single Academic Medical Center.

Molecular genetics &amp; genomic medicine
2026

Alterations in auditory midbrain processing is observed in both female and male mouse model of Fragile X Syndrome.

Neuroscience
2026

Discovery of novel candidate genes for congenital diaphragmatic hernia via whole exome sequencing.

Pediatrics international : official journal of the Japan Pediatric Society
2025

Assessing t(6;11)(q27;q23) and Tetrasomy 21 in Down Syndrome Patient: Cytogenetic Implications in Acute Myeloid Leukemia Pathogenesis.

Journal of the Association of Genetic Technologists
2025

[Clinical and genetic analysis of a child with X-linked Hoyeraal-Hreidarsson syndrome due to variant of DKC1 gene and a literature review].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2025

Genetic activation of ERK2 recapitulates core neurodevelopmental features of Rasopathy syndromes in mice.

bioRxiv : the preprint server for biology
2025

A pediatric case of diphthamide biosynthesis 1 gene defect presenting with developmental delay, short stature, dysmorphic features, and sparse hair (Loucks-Innes syndrome): a case report.

Journal of medical case reports
2025

Two cases of TBL1XR1 heterozygous variants in children: a new splicing site variant identification and functional analysis through molecular docking and molecular dynamics simulation.

Human genomics
2025

16p13.11 deletion/duplication: a large cohort study on prenatal diagnosis, postnatal outcomes, and phenotypic manifestations.

BMC pregnancy and childbirth
2025

Significant improvement of neurological and radiological findings caused by multiple lateral meningocele by cyst-subarachnoid shunt in a 6-year-old boy: case report.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2025

Vein 2 Worlds Collide: May-Thurner Syndrome and Oral Contraceptive Pill Use Precipitating Deep Vein Thrombosis in an Otherwise Healthy Patient.

Journal of investigative medicine high impact case reports
2025

Early onset Arboleda-Tham syndrome due to KAT6A variants: Case report.

Frontiers in genetics
2026

Evaluating the Genetic Overlap Between Congenital Heart Disease and Neuroblastoma Risk.

Pediatric blood &amp; cancer
2026

Insights into KIF11 pathogenesis in microcephaly-lymphedema-chorioretinopathy syndrome from a lymphatic perspective.

JCI insight
2026

Identification of a De Novo MAGEL2 Pathogenic Variant in Schaaf-Yang Syndrome and the Importance of Paternal Allele Confirmation.

Journal of clinical laboratory analysis
2025

Clinical and neuropsychological characterization of Jacobsen syndrome (del11q).

Journal of neurodevelopmental disorders
2025

Prenatally Diagnosed De Novo Interstitial Duplication in 2p21p24.3 with Unique Manifestations: Case Report.

Molecular syndromology
2025

A Novel LRP6 Mutation Highlights the Role of Wnt Signaling in Tooth Agenesis.

Genesis (New York, N.Y. : 2000)
2025

P10 Treatment-refractory psoriasiform dermatitis resulting from a rare genetic alteration in MSMO1 with marked improvement with combined cholesterol and statin use.

The British journal of dermatology
2025

Double Genetic Diagnosis Involving MECP2 and EPHB4 in a Child with Neurodevelopmental Delay and Vascular Anomalies: A Case Report.

Molecular syndromology
2025

Novel KDM3B Variants in Two Chinese Patients With Global Developmental Delay and Autism.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience
2026

Extracellular vesicle dysfunction contributes to synaptic and cognitive deficits in a mouse model of Angelman syndrome.

Progress in neurobiology
2025

Prader-Willi syndrome: A rare genetic disorder with complex clinical manifestations.

Journal of family medicine and primary care
2025

[A case of Harel-Yoon syndrome with seizures caused by an ATAD3A variant].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2026

Altered Auditory Maturation in Fragile X Syndrome and Its Involvement in Audiogenic Seizure Susceptibility.

Autism research : official journal of the International Society for Autism Research
2025

Aripiprazole for treatment of attenuated psychosis syndrome in an adolescent with 22q11.21 deletion syndrome: A case report.

Medicine
2025

Sexual Health and Transition Needs in an Adolescent Girl With Attention-deficit Hyperactivity Disorder and Smith-magenis Syndrome.

Journal of developmental and behavioral pediatrics : JDBP
2025

A new case of Rafiq syndrome with coexisting thyroid dyshormonogenesis type 6 in a Chinese patient: case report and literature review.

Frontiers in endocrinology
2026

Young people's experience of predictive genetic testing for inherited cardiac conditions: a qualitative study.

European journal of human genetics : EJHG
2025

P38α MAPK-induced senescence in cranial suture progenitor cells promotes craniosynostosis.

Communications biology
2026

Comparative analysis of clinical phenotypes and genetic characteristics in MEF2C-associated neurodevelopmental disorders.

Seizure
2025

Comorbidity of Attention Deficit Hyperactivity Disorder (ADHD) and Chung-Jansen Syndrome: Case Report and Review of Literature.

Clinical case reports
2025

Mid-gestational cell-type-specific transcriptomic signatures in the prefrontal and superior temporal cortex in Down syndrome.

Nature communications
2025

Functional analysis across model systems implicates ribosomal proteins in growth and proliferation defects associated with hypoplastic left heart syndrome.

eLife
2025

Hypopituitarism and Rathke's cleft cyst in 48,XXYY Syndrome: new insights into sex chromosome aneuploidies.

Einstein (Sao Paulo, Brazil)

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de perturbação do desenvolvimento intelectual-ataxia-hipotonia-dismorfia facial.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de perturbação do desenvolvimento intelectual-ataxia-hipotonia-dismorfia facial

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Novel Variants in PTPN11, NF1, RASA2, and MAP2K1: Expanding the Molecular Spectrum of RASopathies in a Turkish Cohort.
    Clinical genetics· 2026· PMID 41854160mais citado
  2. Biallelic SUPT4H1 Variants Cause a Multisystem Neurodevelopmental Disorder Associated with Disrupted Transcription.
    Genetics in medicine : official journal of the American College of Medical Genetics· 2026· PMID 41842694mais citado
  3. Protocol for an open-label, randomised, controlled trial to evaluate the efficacy and safety of sotatercept add-on therapy compared with pulmonary vasodilator-based standard of care for pulmonary vasodilator-resistant pulmonary arterial hypertension associated with unrepaired congenital shunts (atrial septal defect, ventricular septal defect or patent ductus arteriosus), including Eisenmenger syndrome: the SuMILE trial.
    BMJ open· 2026· PMID 41819579mais citado
  4. Expanding the Coffin-Siris syndrome spectrum: genetic, dysmorphic, and endocrine findings in eight cases.
    European journal of pediatrics· 2026· PMID 41795723mais citado
  5. Child Neurology: Multiple Genetic Etiologies Causing Dandy-Walker Variant With Microcephaly, Epilepsy, and Global Developmental Delay.
    Neurology· 2026· PMID 41791021mais citado
  6. Bi-allelic variants in FSD1L cause a neurodevelopmental disorder overlapping with L1 syndrome.
    Am J Hum Genet· 2026· PMID 41720098recente
  7. A rare variant of USP9X associated with female-restricted X-linked syndromic intellectual disability.
    Mol Biol Rep· 2025· PMID 41240171recente
  8. Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case.
    BMC Pediatr· 2025· PMID 41188742recente
  9. Whole-genome sequencing reveals individual and cohort level insights into chromosome 9p syndromes.
    Genome Med· 2025· PMID 41137173recente
  10. Pathologies of the cervical spine in skeletal syndromes and dysplasias.
    Orthop Traumatol Surg Res· 2026· PMID 40976314recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:658843(Orphanet)
  2. OMIM OMIM:617330(OMIM)
  3. MONDO:0015021(MONDO)
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome de perturbação do desenvolvimento intelectual-ataxia-hipotonia-dismorfia facial
Compêndio · Raras BR

Síndrome de perturbação do desenvolvimento intelectual-ataxia-hipotonia-dismorfia facial

ORPHA:658843 · MONDO:0015021
Prevalência
<1 / 1 000 000
Casos
62 casos conhecidos
Herança
Autosomal dominant
CID-10
Q87.0 · Síndromes com malformações congênitas afetando predominantemente o aspecto da face
Início
Antenatal, Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C5925144
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades